Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to China's top market regulator, Xinhua News Agency quoted the company's deputy general manager Shi Shengyi as saying on Wednesday.
The Chinese company has two experimental COVID-19 vaccines 鈥
